Siraj Shaikh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Siraj Shaikh has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Kumar Sinha
Department of Orthopedic Surgery, St. Joseph’s University Medical Center, Paterson, NJ
3 shared publications- Adam Elkholy
St. Joseph’s University Medical Center Department of Orthopedic Surgery
2 shared publications - Allen D. Nicholson
Department of Orthopedic Surgery, Monmouth Medical Center, Long Branch, NJ, USA
2 shared publications - Arash Emami
St. Joseph’s University Medical Center Department of Orthopedic Surgery, Paterson, NJ
2 shared publications - Cyrus Emami
Department of Orthopedic Surgery, St. Joseph's University Medical Center, Paterson, NJ 07503, United States
2 shared publications Daniel Coban
Department of Orthopedic Surgery, St. Joseph's University Medical Center, Paterson, NJ 07503, United States
2 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by Wolters Kluwer Health in Spine Open
- Vol. 2 (4)
Cervical Disc Arthroplasty for Myelopathy in McCune-Albright Syndrome
Study Design: Case report. Objective: To describe cervical disc arthroplasty (ACDR) for cervical myelopathy in a patient with McCune-Albright syndrome (MAS) and polyostotic fibrous dysplasia (FD), a context in which poor bone quality is often viewed as a contraindication to arthroplasty. Summary of Background Data: MAS is a rare genetic disorder caused by somatic mutations in the GNAS gene, activating the Gsα-cAMP signaling pathway. The syndrome is characterized by FD, café-au-lait spots, precocious puberty, and endocrinopathies. Spinal FD may cause instability or cord compression, and fusion has traditionally been the preferred surgical approach due to concerns about fixation in dysplastic bone. Reports of successful arthroplasty in MAS are rare. Case: A 39-year-old woman with MAS and polyostotic FD presented with progressive neck pain, bilateral paresthesias, and right-hand weakness. Imaging demonstrated C6–C7 spondylosis with a central disc herniation causing ventral spinal cord compression. Given myelopathy, intact facets, and acceptable endplate integrity, ACDR at C6–C7 was planned with a predefined contingency to convert to fusion if intraoperative bone quality proved unsuitable. Results: Anterior decompression with C6–C7 ACDR was performed uneventfully with stable neuromonitoring and minimal blood loss. At two weeks, the patient reported marked symptom improvement; by six weeks, strength was full and physical therapy commenced. At 18-month follow-up, radiographs demonstrated stable implant position and alignment. MRI showed expected postoperative changes without migration or subsidence. Neurological function and pain relief were sustained. No heterotopic ossification was identified on interval radiographs. Conclusions: This case demonstrates that cervical disc arthroplasty can be a safe and effective option for myelopathy in carefully selected MAS patients with adequate bone quality and stable alignment. Under appropriate conditions, motion preservation may offer an alternative to fusion in metabolic bone disease traditionally considered a contraindication to arthroplasty.
- 23 September 2026
- Published by Wolters Kluwer Health in Spine Open
- Vol. 2 (4)
Open AccessCervical Disc Arthroplasty for Myelopathy in McCune-Albright Syndrome
Study Design: Case report. Objective: To describe cervical disc arthroplasty (ACDR) for cervical myelopathy in a patient with McCune-Albright syndrome (MAS) and polyostotic fibrous dysplasia (FD), a context in which poor bone quality is often viewed as a contraindication to arthroplasty. Summary of Background Data: MAS is a rare genetic disorder caused by somatic mutations in the GNAS gene, activating the Gsα-cAMP signaling pathway. The syndrome is characterized by FD, café-au-lait spots, precocious puberty, and endocrinopathies. Spinal FD may cause instability or cord compression, and fusion has traditionally been the preferred surgical approach due to concerns about fixation in dysplastic bone. Reports of successful arthroplasty in MAS are rare. Case: A 39-year-old woman with MAS and polyostotic FD presented with progressive neck pain, bilateral paresthesias, and right-hand weakness. Imaging demonstrated C6–C7 spondylosis with a central disc herniation causing ventral spinal cord compression. Given myelopathy, intact facets, and acceptable endplate integrity, ACDR at C6–C7 was planned with a predefined contingency to convert to fusion if intraoperative bone quality proved unsuitable. Results: Anterior decompression with C6–C7 ACDR was performed uneventfully with stable neuromonitoring and minimal blood loss. At two weeks, the patient reported marked symptom improvement; by six weeks, strength was full and physical therapy commenced. At 18-month follow-up, radiographs demonstrated stable implant position and alignment. MRI showed expected postoperative changes without migration or subsidence. Neurological function and pain relief were sustained. No heterotopic ossification was identified on interval radiographs. Conclusions: This case demonstrates that cervical disc arthroplasty can be a safe and effective option for myelopathy in carefully selected MAS patients with adequate bone quality and stable alignment. Under appropriate conditions, motion preservation may offer an alternative to fusion in metabolic bone disease traditionally considered a contraindication to arthroplasty.
- Open Access
- 23 September 2026
- Published by Wolters Kluwer Health in Spine Open
- Vol. 2 (4)
Comparative Clinical and Radiographic Outcomes of Mini-ALIF With Percutaneous Fixation Versus MI-TLIF in Intermediate-to-High-Grade Isthmic Spondylolisthesis
Study Design: Retrospective cohort study. Objective: To compare clinical outcomes, radiographic alignment, and fusion durability between minianterior lumbar interbody fusion with percutaneous pedicle screw fixation (mini-ALIF+PPSF) and minimally invasive transforaminal lumbar interbody fusion (MI-TLIF) in adults with intermediate-to-high-grade isthmic spondylolisthesis (IS). Summary of Background Data: Intermediate-to-high-grade IS places high mechanical demands on fusion constructs. The two principal minimally invasive interbody strategies are mini-ALIF+PPSF and MI-TLIF, yet comparative data focused on fusion durability, revision timing, and sagittal alignment are limited. Methods: Adult patients (18 y or older) with IS (Meyerding grade II or higher) who underwent 1 to 2 level instrumented fusion between L4 and S1 (2012–2020) were included. Degenerative etiologies were excluded. Patients were counseled on both procedures; approach selection reflected shared decision-making incorporating patient preference, surgeon preference, and patient-specific anatomic/risk factors influencing anterior exposure. Demographics, complications, pseudoarthrosis, revision rate and timing, radiographic parameters (PI, PT, SS, LL, and slip angle), and PROMs (VAS-back, VAS-leg, and ODI) were compared. Minimum follow-up was 24 months. Results: Fifty-two patients met criteria (mini-ALIF + PPSF: n=32; MI-TLIF: n=20). Baseline demographics and follow-up were similar. Pseudoarthrosis was lower with mini-ALIF + PPSF (0% vs . 15%, P =0.024). Mean time to revision was longer after mini-ALIF + PPSF (25.5 vs . 10.5 mo, P =0.044), despite similar revision rates. Radiographic parameters and changes were not significantly different between groups. Both cohorts demonstrated significant improvement in VAS and ODI, with no significant between-group differences. Complication rates were low and comparable. Conclusion: Both mini-ALIF+PPSF and MI-TLIF yield meaningful improvement in intermediate-to-high-grade IS. Mini-ALIF+PPSF was associated with superior fusion durability and delayed revision timing, with comparable alignment correction and PROM improvement.
- 23 September 2026
- Published by Wolters Kluwer Health in Spine Open
- Vol. 2 (4)
Open AccessComparative Clinical and Radiographic Outcomes of Mini-ALIF With Percutaneous Fixation Versus MI-TLIF in Intermediate-to-High-Grade Isthmic Spondylolisthesis
Study Design: Retrospective cohort study. Objective: To compare clinical outcomes, radiographic alignment, and fusion durability between minianterior lumbar interbody fusion with percutaneous pedicle screw fixation (mini-ALIF+PPSF) and minimally invasive transforaminal lumbar interbody fusion (MI-TLIF) in adults with intermediate-to-high-grade isthmic spondylolisthesis (IS). Summary of Background Data: Intermediate-to-high-grade IS places high mechanical demands on fusion constructs. The two principal minimally invasive interbody strategies are mini-ALIF+PPSF and MI-TLIF, yet comparative data focused on fusion durability, revision timing, and sagittal alignment are limited. Methods: Adult patients (18 y or older) with IS (Meyerding grade II or higher) who underwent 1 to 2 level instrumented fusion between L4 and S1 (2012–2020) were included. Degenerative etiologies were excluded. Patients were counseled on both procedures; approach selection reflected shared decision-making incorporating patient preference, surgeon preference, and patient-specific anatomic/risk factors influencing anterior exposure. Demographics, complications, pseudoarthrosis, revision rate and timing, radiographic parameters (PI, PT, SS, LL, and slip angle), and PROMs (VAS-back, VAS-leg, and ODI) were compared. Minimum follow-up was 24 months. Results: Fifty-two patients met criteria (mini-ALIF + PPSF: n=32; MI-TLIF: n=20). Baseline demographics and follow-up were similar. Pseudoarthrosis was lower with mini-ALIF + PPSF (0% vs . 15%, P =0.024). Mean time to revision was longer after mini-ALIF + PPSF (25.5 vs . 10.5 mo, P =0.044), despite similar revision rates. Radiographic parameters and changes were not significantly different between groups. Both cohorts demonstrated significant improvement in VAS and ODI, with no significant between-group differences. Complication rates were low and comparable. Conclusion: Both mini-ALIF+PPSF and MI-TLIF yield meaningful improvement in intermediate-to-high-grade IS. Mini-ALIF+PPSF was associated with superior fusion durability and delayed revision timing, with comparable alignment correction and PROM improvement.
- 16 June 2026
- Published by Wolters Kluwer Health in Spine
- Vol. 51 (21) , E548-E557
Concordance and Variability in Thoracolumbar Injury Classification and Severity Score (TLICS)-Guided Treatment Decision-Making
Study Design.: Systematic review and pooled analysis. Objective.: To evaluate the concordance between Thoracolumbar Injury Classification and Severity Score (TLICS) recommendations and actual treatment decisions in thoracolumbar trauma. Summary of Background Data.: TLICS is widely used to guide management of thoracolumbar fractures, recommending nonoperative treatment for scores ≤3 and operative intervention for scores ≥5. However, treatment variability may occur in cases with indeterminate scores, uncertainty in posterior ligamentous complex (PLC) integrity, or clinical modifiers not fully captured within the scoring framework. Methods.: A systematic review of PubMed and Embase databases was performed. Studies reporting TLICS scores and corresponding treatment decisions were included. Pooled proportions were calculated for operative treatment in TLICS ≤3, nonoperative treatment in TLICS ≥5, operative treatment in TLICS =4, and delayed surgery following initial nonoperative management. Heterogeneity was assessed using I² statistic. Results.: Fourteen studies encompassing 1,221 patients were included. Among patients with TLICS ≤3, 13.7% (95% CI 8.7–20.9) underwent operative treatment. In TLICS ≥5 patients, 6.1% (95% CI 3.2–11.3) were treated nonoperatively. Operative treatment in TLICS=4 occurred in 49.6% (95% CI 37.6–61.6). Delayed surgery after initial nonoperative management occurred in 7.5% (95% CI 2.9–18.2). Significant heterogeneity was observed across studies. Conclusion.: TLICS-based recommendations were concordant with treatment decisions in most low- and high-score thoracolumbar fractures. Observed treatment variability appeared to arise in predictable settings, including uncertainty in PLC assessment, borderline injury morphology, and patient-specific clinical modifiers. These findings support continued use of TLICS as a decision-support framework integrated with clinical judgment while identifying areas where future refinement of thoracolumbar trauma algorithms may be informed by evolving clinical practice.
- 16 June 2026
- Published by Wolters Kluwer Health in Spine
- Vol. 51 (21) , E548-E557
Concordance and Variability in Thoracolumbar Injury Classification and Severity Score (TLICS)-Guided Treatment Decision-Making
Study Design.: Systematic review and pooled analysis. Objective.: To evaluate the concordance between Thoracolumbar Injury Classification and Severity Score (TLICS) recommendations and actual treatment decisions in thoracolumbar trauma. Summary of Background Data.: TLICS is widely used to guide management of thoracolumbar fractures, recommending nonoperative treatment for scores ≤3 and operative intervention for scores ≥5. However, treatment variability may occur in cases with indeterminate scores, uncertainty in posterior ligamentous complex (PLC) integrity, or clinical modifiers not fully captured within the scoring framework. Methods.: A systematic review of PubMed and Embase databases was performed. Studies reporting TLICS scores and corresponding treatment decisions were included. Pooled proportions were calculated for operative treatment in TLICS ≤3, nonoperative treatment in TLICS ≥5, operative treatment in TLICS =4, and delayed surgery following initial nonoperative management. Heterogeneity was assessed using I² statistic. Results.: Fourteen studies encompassing 1,221 patients were included. Among patients with TLICS ≤3, 13.7% (95% CI 8.7–20.9) underwent operative treatment. In TLICS ≥5 patients, 6.1% (95% CI 3.2–11.3) were treated nonoperatively. Operative treatment in TLICS=4 occurred in 49.6% (95% CI 37.6–61.6). Delayed surgery after initial nonoperative management occurred in 7.5% (95% CI 2.9–18.2). Significant heterogeneity was observed across studies. Conclusion.: TLICS-based recommendations were concordant with treatment decisions in most low- and high-score thoracolumbar fractures. Observed treatment variability appeared to arise in predictable settings, including uncertainty in PLC assessment, borderline injury morphology, and patient-specific clinical modifiers. These findings support continued use of TLICS as a decision-support framework integrated with clinical judgment while identifying areas where future refinement of thoracolumbar trauma algorithms may be informed by evolving clinical practice.
- Open Access
- 9 June 2026
- Published by Elsevier in North American Spine Society Journal (NASSJ)
- Vol. 27, 100917
ChatGPT improves readability in validated spine patient-reported outcome measures
- 9 June 2026
- Published by Elsevier in North American Spine Society Journal (NASSJ)
- Vol. 27, 100917
Open AccessChatGPT improves readability in validated spine patient-reported outcome measures
- Open Access
- 1 April 2026
- Published by AME Publishing Company in Journal of Spine Surgery
- Vol. 12 (4) , 49
Clinical and radiographic outcomes of three-level anterior cervical discectomy and fusion using allograft cellular bone matrix
Background: Achieving reliable fusion in multilevel anterior cervical discectomy and fusion (ACDF) remains challenging, with increasing rates of pseudarthrosis and approach-related complications as the number of fused levels increases. Selection of an optimal biologic adjunct is particularly important in three-level constructs, yet data on allograft cellular bone matrix (ACBM) remain limited. This study describes the clinical and radiographic outcomes of patients undergoing three-level ACDF augmented with ACBM. Methods: A retrospective cohort study was conducted at a single academic institution. A total of 103 adults who underwent primary three-level ACDF with ACBM augmentation between 2012 and 2020 and had a minimum of 24 months of follow-up were included. Medical records and imaging were reviewed for demographic characteristics, perioperative variables, complications, and outcomes. Functional outcomes were assessed using the Neck Disability Index (NDI) and Visual Analog Scale (VAS) scores for neck and arm pain. Fusion was evaluated using serial plain radiographs, with advanced imaging obtained selectively when findings were equivocal. Changes in NDI and VAS scores from baseline to 24 months were analyzed using paired Student’s t-tests. Results: The mean follow-up duration was 45.5±15.5 months. Patients demonstrated significant improvements in functional outcomes, with mean NDI improving from 26.4±8.2 preoperatively to 11.2±4.5 at 24 months (PConclusions: In this retrospective cohort, three-level ACDF augmented with ACBM was associated with meaningful improvements in pain and functional outcomes, and a low incidence of pseudarthrosis. These findings support the feasibility of ACBM as a biologic adjunct in multilevel anterior cervical fusion.
- 1 April 2026
- Published by AME Publishing Company in Journal of Spine Surgery
- Vol. 12 (4) , 49
Open AccessClinical and radiographic outcomes of three-level anterior cervical discectomy and fusion using allograft cellular bone matrix
Background: Achieving reliable fusion in multilevel anterior cervical discectomy and fusion (ACDF) remains challenging, with increasing rates of pseudarthrosis and approach-related complications as the number of fused levels increases. Selection of an optimal biologic adjunct is particularly important in three-level constructs, yet data on allograft cellular bone matrix (ACBM) remain limited. This study describes the clinical and radiographic outcomes of patients undergoing three-level ACDF augmented with ACBM. Methods: A retrospective cohort study was conducted at a single academic institution. A total of 103 adults who underwent primary three-level ACDF with ACBM augmentation between 2012 and 2020 and had a minimum of 24 months of follow-up were included. Medical records and imaging were reviewed for demographic characteristics, perioperative variables, complications, and outcomes. Functional outcomes were assessed using the Neck Disability Index (NDI) and Visual Analog Scale (VAS) scores for neck and arm pain. Fusion was evaluated using serial plain radiographs, with advanced imaging obtained selectively when findings were equivocal. Changes in NDI and VAS scores from baseline to 24 months were analyzed using paired Student’s t-tests. Results: The mean follow-up duration was 45.5±15.5 months. Patients demonstrated significant improvements in functional outcomes, with mean NDI improving from 26.4±8.2 preoperatively to 11.2±4.5 at 24 months (PConclusions: In this retrospective cohort, three-level ACDF augmented with ACBM was associated with meaningful improvements in pain and functional outcomes, and a low incidence of pseudarthrosis. These findings support the feasibility of ACBM as a biologic adjunct in multilevel anterior cervical fusion.
- Open Access
- 26 November 2025
- Published by Wolters Kluwer Health in Spine Open
- Vol. 1 (2)
Clinical Validation of A Novel Psoas Classification for Optimal L4 to L5 Access: OLIF versus LLIF
Study Design: Retrospective cohort study. Objective: To evaluate neurovascular complications of oblique lumbar interbody fusion (OLIF) and lateral lumbar interbody fusion (LLIF) at L4 to L5 stratified by psoas morphology using the Emami et al. classification system. Summary of Background Data: OLIF and LLIF are commonly used to treat L4 to L5 degenerative spondylolisthesis. The Emami et al. classification system categorizes the anterior-posterior position of the psoas muscle and may help guide surgical approaches to mitigate neurovascular risk. No prior study has correlated this classification system with neurovascular complication profiles. Methods: We retrospectively reviewed 350 patients who underwent single-level OLIF (n=178) or LLIF (n=172) at L4 to L5 for low-grade degenerative spondylolisthesis between 2012 and 2022. Preoperative axial T2-weighted MRI at the inferior endplate of L4 was used to classify psoas morphology: class A (>2 mm anterior to L4), class B (≤2 mm anterior or posterior to L4), and class C (>2 mm posterior to L4). Neurological and vascular complications were analyzed using multivariable logistic regression. Results: Neurological complications were more frequent in LLIF than OLIF (13.4% vs. 2.8%, P vs. 2.3% OLIF, P P =0.019). Vascular complications were more common in OLIF (5.1% vs. 1.2%, P =0.026), especially in class C (13.3% OLIF vs. 1.8% LLIF, P =0.011). Class A predicted neurological injury with LLIF (OR: 4.52, P P =0.003). Conclusions: Psoas morphology independently predicts approach-specific neurovascular complication risk. Class A favors OLIF due to lower neurological risk; class C favors LLIF due to lower vascular risk. Class B presents an intermediate risk. Preoperative psoas categorization using the Emami et al. classification system may optimize approach selection and improve patient safety.
- 26 November 2025
- Published by Wolters Kluwer Health in Spine Open
- Vol. 1 (2)
Open AccessClinical Validation of A Novel Psoas Classification for Optimal L4 to L5 Access: OLIF versus LLIF
Study Design: Retrospective cohort study. Objective: To evaluate neurovascular complications of oblique lumbar interbody fusion (OLIF) and lateral lumbar interbody fusion (LLIF) at L4 to L5 stratified by psoas morphology using the Emami et al. classification system. Summary of Background Data: OLIF and LLIF are commonly used to treat L4 to L5 degenerative spondylolisthesis. The Emami et al. classification system categorizes the anterior-posterior position of the psoas muscle and may help guide surgical approaches to mitigate neurovascular risk. No prior study has correlated this classification system with neurovascular complication profiles. Methods: We retrospectively reviewed 350 patients who underwent single-level OLIF (n=178) or LLIF (n=172) at L4 to L5 for low-grade degenerative spondylolisthesis between 2012 and 2022. Preoperative axial T2-weighted MRI at the inferior endplate of L4 was used to classify psoas morphology: class A (>2 mm anterior to L4), class B (≤2 mm anterior or posterior to L4), and class C (>2 mm posterior to L4). Neurological and vascular complications were analyzed using multivariable logistic regression. Results: Neurological complications were more frequent in LLIF than OLIF (13.4% vs. 2.8%, P vs. 2.3% OLIF, P P =0.019). Vascular complications were more common in OLIF (5.1% vs. 1.2%, P =0.026), especially in class C (13.3% OLIF vs. 1.8% LLIF, P =0.011). Class A predicted neurological injury with LLIF (OR: 4.52, P P =0.003). Conclusions: Psoas morphology independently predicts approach-specific neurovascular complication risk. Class A favors OLIF due to lower neurological risk; class C favors LLIF due to lower vascular risk. Class B presents an intermediate risk. Preoperative psoas categorization using the Emami et al. classification system may optimize approach selection and improve patient safety.
- Open Access
- 1 January 2024
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 9 (1)
The Rising Quality of Randomized Controlled Trials in The Journal of Bone & Joint Surgery
Background: Previous reports found that 40% of randomized controlled trials (RCTs) published in The Journal of Bone & Joint Surgery (JBJS) from 1988 to 2000 and 47% of those published from 2001 to 2013 were of high quality. The purpose of this study was to assess the quality of RCTs published from 2014 to 2022 in JBJS and to compare these findings with those of prior analyses in order to identify trends over time and areas for continued improvement. Methods: PubMed was searched for the term “randomized controlled trial” to identify studies published in JBJS from 2014 to 2022. Each included RCT was evaluated with use of the Detsky score and a risk-of-bias assessment modified from the Cochrane tool. These evaluations were then compared with previous evaluations of RCTs from the 1988 to 2000 and 2001 to 2013 periods with use of independent-sample t tests. A transformed Detsky score of >75% and a modified risk-of-bias score of ≥8 were defined as being indicative of high quality. Results: A total of 218 RCTs were published in JBJS from 2014 to 2022. An a priori sample size was calculated in 183 studies (83.9%). A total of 152 (83.1%) of the 183 studies enrolled the calculated number of patients, of which 126 (82.9%) maintained an adequate number at the time of final follow-up. Most RCTs were conducted at a single center (146 of 218; 67%), evaluated a surgical intervention (162 of 218; 74%), and reported positive results (142 of 218; 65%). The mean transformed Detsky score was 85% ± 10% (95% confidence interval, 83.7% to 86.3%), with 82% of trials (179 of 218) scored as high quality. The mean transformed Detsky score from 2014 to 2022 was higher than that from 1988 to 2000 and that from 2001 to 2013 (85% versus 76% and 68%, respectively; p < 0.001). The mean modified risk-of-bias score was 7 ± 1, with 42% of trials (92 of 218) scored as high quality. RCTs published from 2014 to 2022 had a higher mean modified risk-of-bias score than those published from 2001 to 2013 (7 ± 1 versus 6 ± 1; p < 0.001). Compared with the 2001 to 2013 and 2014 to 2022 periods, the 1988 to 2000 period had a greater proportion of trials that reported positive results (51% and 65% versus 82%, respectively; p < 0.001) and that included data from multiple centers (31% and 33% versus 67%; p < 0.001). Conclusions: The quality of RCTs published in JBJS from 2014 to 2022 has improved from that reported previously, as demonstrated by the increases in the modified risk-of-bias score and transformed Detsky score from prior periods. This may be the result of journal policies such as the requirements of CONSORT adherence and prospective trial registration. Investigators should focus on improving the clarity of reporting, limiting attrition bias, and making efforts to blind support staff in order to increase the quality of future RCTs. Clinical Relevance: Improving the quality of RCTs is crucial given their potential to influence current clinical practice.
- 1 January 2024
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 9 (1)
Open AccessThe Rising Quality of Randomized Controlled Trials in The Journal of Bone & Joint Surgery
Background: Previous reports found that 40% of randomized controlled trials (RCTs) published in The Journal of Bone & Joint Surgery (JBJS) from 1988 to 2000 and 47% of those published from 2001 to 2013 were of high quality. The purpose of this study was to assess the quality of RCTs published from 2014 to 2022 in JBJS and to compare these findings with those of prior analyses in order to identify trends over time and areas for continued improvement. Methods: PubMed was searched for the term “randomized controlled trial” to identify studies published in JBJS from 2014 to 2022. Each included RCT was evaluated with use of the Detsky score and a risk-of-bias assessment modified from the Cochrane tool. These evaluations were then compared with previous evaluations of RCTs from the 1988 to 2000 and 2001 to 2013 periods with use of independent-sample t tests. A transformed Detsky score of >75% and a modified risk-of-bias score of ≥8 were defined as being indicative of high quality. Results: A total of 218 RCTs were published in JBJS from 2014 to 2022. An a priori sample size was calculated in 183 studies (83.9%). A total of 152 (83.1%) of the 183 studies enrolled the calculated number of patients, of which 126 (82.9%) maintained an adequate number at the time of final follow-up. Most RCTs were conducted at a single center (146 of 218; 67%), evaluated a surgical intervention (162 of 218; 74%), and reported positive results (142 of 218; 65%). The mean transformed Detsky score was 85% ± 10% (95% confidence interval, 83.7% to 86.3%), with 82% of trials (179 of 218) scored as high quality. The mean transformed Detsky score from 2014 to 2022 was higher than that from 1988 to 2000 and that from 2001 to 2013 (85% versus 76% and 68%, respectively; p < 0.001). The mean modified risk-of-bias score was 7 ± 1, with 42% of trials (92 of 218) scored as high quality. RCTs published from 2014 to 2022 had a higher mean modified risk-of-bias score than those published from 2001 to 2013 (7 ± 1 versus 6 ± 1; p < 0.001). Compared with the 2001 to 2013 and 2014 to 2022 periods, the 1988 to 2000 period had a greater proportion of trials that reported positive results (51% and 65% versus 82%, respectively; p < 0.001) and that included data from multiple centers (31% and 33% versus 67%; p < 0.001). Conclusions: The quality of RCTs published in JBJS from 2014 to 2022 has improved from that reported previously, as demonstrated by the increases in the modified risk-of-bias score and transformed Detsky score from prior periods. This may be the result of journal policies such as the requirements of CONSORT adherence and prospective trial registration. Investigators should focus on improving the clarity of reporting, limiting attrition bias, and making efforts to blind support staff in order to increase the quality of future RCTs. Clinical Relevance: Improving the quality of RCTs is crucial given their potential to influence current clinical practice.
- Open Access
- 5 June 2023
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 481 (7) , 1449-1450
Letter to the Editor: Which Factors Are Considered by Patients When Considering Total Joint Arthroplasty? A Discrete-choice Experiment
- 5 June 2023
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 481 (7) , 1449-1450
Open AccessLetter to the Editor: Which Factors Are Considered by Patients When Considering Total Joint Arthroplasty? A Discrete-choice Experiment
- 20 April 2023
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 105 (15) , 1205-1213
National Institutes of Health Funding to Departments of Orthopaedic Surgery at U.S. Medical Schools from 2015 to 2021
Background: National Institutes of Health (NIH) funding of orthopaedic surgery departments has historically lagged behind that of other surgical disciplines. In this study, we present an updated analysis of NIH grants awarded to orthopaedic surgery departments at U.S. medical schools and an evaluation of the characteristics of NIH-funded principal investigators (PIs). Methods: The NIH Research Portfolio Online Reporting Tools Expenditures and Results (RePORTER) database was queried for grants awarded to orthopaedic surgery departments in the 2015 to 2021 fiscal years. Funding totals were calculated for 4 categories: award mechanism, awarding institute, recipient institute, and PI. Trends in funding from 2015 to 2021 were determined and compared with the annual NIH budget. Funding awarded to orthopaedic surgery departments was compared with awards received by other surgical specialties in 2021. The characteristics of NIH-funded PIs and co-PIs were evaluated. Funding awarded to orthopaedic surgery departments in 2021 was compared with funding in 2014 as reported in a previous study. Results: In 2021, 287 grants were awarded to 187 PIs at 47 orthopaedic surgery departments for a total of $104,710,841, representing 0.4% of the overall NIH budget. The top 5 departments earned $41,750,321 (39.9%) of the total NIH funding for orthopaedic surgery. From 2015 to 2021, total funding increased by 79.7% (p < 0.001), but the rate of increase was not significantly different from that of the overall annual NIH budget (p = 0.469). In 2021, grants were most commonly awarded via the R01 mechanism (70.0% of total funding), with a median annual award of $397,144 (interquartile range [IQR], $335,017 to $491,248). The majority of grants (70.0%) supported basic science research, followed by translational (12.2%), clinical (9.4%), and educational (8.4%) research. NIH funding did not vary by the gender of the PI (p = 0.505), and the proportion of female PIs was significantly greater in 2021 than in 2014 (33.9% versus 20.5%, p = 0.009). Compared with other surgical departments, orthopaedic surgery departments ranked second-lowest in terms of the total NIH funding received in 2021. Conclusions: NIH funding to orthopaedic surgery departments continues to be limited and lags behind that of other surgical subspecialties, which may create challenges in addressing the rising burden of musculoskeletal disease in the U.S. These findings highlight the importance of efforts to identify barriers to grant procurement in orthopaedic surgery.
- 20 April 2023
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 105 (15) , 1205-1213
National Institutes of Health Funding to Departments of Orthopaedic Surgery at U.S. Medical Schools from 2015 to 2021
Background: National Institutes of Health (NIH) funding of orthopaedic surgery departments has historically lagged behind that of other surgical disciplines. In this study, we present an updated analysis of NIH grants awarded to orthopaedic surgery departments at U.S. medical schools and an evaluation of the characteristics of NIH-funded principal investigators (PIs). Methods: The NIH Research Portfolio Online Reporting Tools Expenditures and Results (RePORTER) database was queried for grants awarded to orthopaedic surgery departments in the 2015 to 2021 fiscal years. Funding totals were calculated for 4 categories: award mechanism, awarding institute, recipient institute, and PI. Trends in funding from 2015 to 2021 were determined and compared with the annual NIH budget. Funding awarded to orthopaedic surgery departments was compared with awards received by other surgical specialties in 2021. The characteristics of NIH-funded PIs and co-PIs were evaluated. Funding awarded to orthopaedic surgery departments in 2021 was compared with funding in 2014 as reported in a previous study. Results: In 2021, 287 grants were awarded to 187 PIs at 47 orthopaedic surgery departments for a total of $104,710,841, representing 0.4% of the overall NIH budget. The top 5 departments earned $41,750,321 (39.9%) of the total NIH funding for orthopaedic surgery. From 2015 to 2021, total funding increased by 79.7% (p < 0.001), but the rate of increase was not significantly different from that of the overall annual NIH budget (p = 0.469). In 2021, grants were most commonly awarded via the R01 mechanism (70.0% of total funding), with a median annual award of $397,144 (interquartile range [IQR], $335,017 to $491,248). The majority of grants (70.0%) supported basic science research, followed by translational (12.2%), clinical (9.4%), and educational (8.4%) research. NIH funding did not vary by the gender of the PI (p = 0.505), and the proportion of female PIs was significantly greater in 2021 than in 2014 (33.9% versus 20.5%, p = 0.009). Compared with other surgical departments, orthopaedic surgery departments ranked second-lowest in terms of the total NIH funding received in 2021. Conclusions: NIH funding to orthopaedic surgery departments continues to be limited and lags behind that of other surgical subspecialties, which may create challenges in addressing the rising burden of musculoskeletal disease in the U.S. These findings highlight the importance of efforts to identify barriers to grant procurement in orthopaedic surgery.